Hollsteen
← Veeva

SG&A

Flow – sum over the period · $M

QuartersFiscal years

$MSG&A · Q1 FY2016: $24.0M · derived · 10-Q 0001564590-15-004860 filed Jun 4, 2015SG&A · Q2 FY2016: $27.0M · derived · 10-Q 0001564590-15-007757 filed Sep 4, 2015SG&A · Q3 FY2016: $32.0M · derived · 10-Q 0001564590-15-011387 filed Dec 10, 2015SG&A · Q4 FY2016: $39.0M · derived · 10-K 0001564590-17-005637 filed Mar 30, 2017SG&A · Q1 FY2017: $39.0M · derived · 10-Q 0001564590-16-020379 filed Jun 8, 2016SG&A · Q2 FY2017: $42.0M · derived · 10-Q 0001564590-16-025058 filed Sep 8, 2016SG&A · Q3 FY2017: $40.0M · derived · 10-Q 0001564590-16-030006 filed Dec 8, 2016SG&A · Q4 FY2017: $45.0M · derived · 10-K 0001564590-18-007164 filed Mar 30, 2018SG&A · Q1 FY2018: $44.0M · derived · 10-Q 0001564590-18-015244 filed Jun 7, 2018SG&A · Q2 FY2018: $47.0M · derived · 10-Q 0001564590-18-022767 filed Sep 6, 2018SG&A · Q3 FY2018: $47.0M · derived · 10-Q 0001564590-18-030635 filed Dec 7, 2018SG&A · Q4 FY2018: $52.0M · derived · 10-K 0001564590-19-009853 filed Mar 28, 2019SG&A · Q1 FY2019: $54.0M · derived · 10-Q 0001564590-18-015244 filed Jun 7, 2018SG&A · Q2 FY2019: $59.0M · derived · 10-Q 0001564590-18-022767 filed Sep 6, 2018SG&A · Q3 FY2019: $60.0M · derived · 10-Q 0001564590-18-030635 filed Dec 7, 2018SG&A · Q4 FY2019: $62.0M · derived · 10-K 0001628280-20-004385 filed Mar 30, 2020SG&A · Q1 FY2020: $63.0M · derived · 10-Q 0001564590-19-021933 filed Jun 6, 2019SG&A · Q2 FY2020: $72.0M · derived · 10-Q 0001628280-19-011445 filed Sep 5, 2019SG&A · Q3 FY2020: $74.0M · derived · 10-Q 0001628280-19-014779 filed Dec 5, 2019SG&A · Q4 FY2020: $96.0M · derived · 10-K 0001393052-21-000015 filed Mar 30, 2021SG&A · Q1 FY2021: $92.0M · derived · 10-Q 0001628280-20-008982 filed Jun 4, 2020SG&A · Q2 FY2021: $96.0M · derived · 10-Q 0001628279-20-000207 filed Sep 8, 2020SG&A · Q3 FY2021: $93.0M · derived · 10-Q 0001628280-20-017286 filed Dec 9, 2020SG&A · Q4 FY2021: $102M · derived · 10-K 0001393052-22-000017 filed Mar 30, 2022SG&A · Q1 FY2022: $106M · derived · 10-Q 0001393052-21-000028 filed Jun 4, 2021SG&A · Q2 FY2022: $114M · derived · 10-Q 0001393052-21-000034 filed Sep 3, 2021SG&A · Q3 FY2022: $115M · derived · 10-Q 0001393052-21-000040 filed Dec 3, 2021SG&A · Q4 FY2022: $125M · derived · 10-K 0001393052-23-000025 filed Mar 30, 2023SG&A · Q1 FY2023: $124M · derived · 10-Q 0001393052-22-000025 filed Jun 3, 2022SG&A · Q2 FY2023: $147M · derived · 10-Q 0001393052-22-000036 filed Sep 2, 2022SG&A · Q3 FY2023: $147M · derived · 10-Q 0001393052-22-000048 filed Dec 7, 2022SG&A · Q4 FY2023: $148M · derived · 10-K 0001393052-24-000013 filed Mar 25, 2024SG&A · Q1 FY2024: $151M · derived · 10-Q 0001393052-23-000034 filed Jun 2, 2023SG&A · Q2 FY2024: $160M · derived · 10-Q 0001393052-23-000051 filed Sep 1, 2023SG&A · Q3 FY2024: $159M · derived · 10-Q 0001393052-23-000066 filed Dec 7, 2023SG&A · Q4 FY2024: $158M · derived · 10-K 0001393052-25-000022 filed Mar 24, 2025SG&A · Q1 FY2025: $159M · derived · 10-Q 0001393052-24-000024 filed Jun 4, 2024SG&A · Q2 FY2025: $163M · derived · 10-Q 0001393052-24-000062 filed Sep 4, 2024SG&A · Q3 FY2025: $171M · derived · 10-Q 0001393052-24-000075 filed Dec 9, 2024SG&A · Q4 FY2025: $170M · derived · 10-K 0001393052-26-000014 filed Mar 20, 2026SG&A · Q1 FY2026: $167M · derived · 10-Q 0001393052-25-000042 filed Jun 2, 2025SG&A · Q2 FY2026: $205M · derived · 10-Q 0001393052-25-000067 filed Aug 29, 2025SG&A · Q3 FY2026: $179M · derived · 10-Q 0001393052-25-000078 filed Nov 21, 2025SG&A · Q4 FY2026: $178M · derived · 10-K 0001393052-26-000014 filed Mar 20, 2026SG&A · Q1 FY2027: $181M · derived · 10-Q 0001393052-26-000026 filed Jun 5, 2026SG&A · Q2 FY2027: $198M · derived · 10-Q 0001393052-26-000036 filed Aug 27, 2026124a198a24a205aQ1 FY2016Q2 FY2027Q1 FY2023
$MSG&A · Q1 FY2022: $106M · derived · 10-Q 0001393052-21-000028 filed Jun 4, 2021SG&A · Q2 FY2022: $114M · derived · 10-Q 0001393052-21-000034 filed Sep 3, 2021SG&A · Q3 FY2022: $115M · derived · 10-Q 0001393052-21-000040 filed Dec 3, 2021SG&A · Q4 FY2022: $125M · derived · 10-K 0001393052-23-000025 filed Mar 30, 2023SG&A · Q1 FY2023: $124M · derived · 10-Q 0001393052-22-000025 filed Jun 3, 2022SG&A · Q2 FY2023: $147M · derived · 10-Q 0001393052-22-000036 filed Sep 2, 2022SG&A · Q3 FY2023: $147M · derived · 10-Q 0001393052-22-000048 filed Dec 7, 2022SG&A · Q4 FY2023: $148M · derived · 10-K 0001393052-24-000013 filed Mar 25, 2024124a148a106aQ1 FY2022Q4 FY2023Q1 FY2023
Q1 FY2023
124a$M
derived
All values (46)
PeriodValue ($M)Status
Q2 FY2027198derived
Q1 FY2027181derived
Q4 FY2026178derived
Q3 FY2026179derived
Q2 FY2026205derived
Q1 FY2026167derived
Q4 FY2025170derived
Q3 FY2025171derived
Q2 FY2025163derived
Q1 FY2025159derived
Q4 FY2024158derived
Q3 FY2024159derived
Q2 FY2024160derived
Q1 FY2024151derived
Q4 FY2023148derived
Q3 FY2023147derived
Q2 FY2023147derived
Q1 FY2023124derived
Q4 FY2022125derived
Q3 FY2022115derived
Q2 FY2022114derived
Q1 FY2022106derived
Q4 FY2021102derived
Q3 FY202193derived
Q2 FY202196derived
Q1 FY202192derived
Q4 FY202096derived
Q3 FY202074derived
Q2 FY202072derived
Q1 FY202063derived
Q4 FY201962derived
Q3 FY201960derived
Q2 FY201959derived
Q1 FY201954derived
Q4 FY201852derived
Q3 FY201847derived
Q2 FY201847derived
Q1 FY201844derived
Q4 FY201745derived
Q3 FY201740derived
Q2 FY201742derived
Q1 FY201739derived
Q4 FY201639derived
Q3 FY201632derived
Q2 FY201627derived
Q1 FY201624derived

CSV with all sources · Technical ID: sga

More metrics for Veeva

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region

Sources & calculation
Value
$124M (derived)
Period
Q1 FY2023, ended Apr 30, 2022 · quarterly value (3 months, not cumulative)
Calculation
sga = Sales & marketing 76M + G&A 48M = $124M (Summanden: berichtete SEC-Werte derselben Periode)
Source
10-Q, filed Jun 3, 2022 · 0001393052-22-000025
Location
sga = + sm + ga
Confidence
0.95 – berechnet aus berichteten SEC-Werten derselben Periode (e.g. SG&A = S&M + G&A)

Versions

v1$124MJun 3, 202210-Q 0001393052-22-000025derived · confidence 0.95 · current